Daftar Pustaka

1. Bratawidjaja KG: Imunologi Dasar. Gaya Baru: Edisi ke-7. J akarta,

2006. Hal. 13-15, 391-408.
2. Khera A. Biomarkers in Heart Diseases. In: Lemos J A (Ed):
Biomarkers in Heart Disease. BlackWell Publishing: 1st Edition.
Massachussetts,2008,p. 161-180.
3. Blake GJ , Ridker PM. C-Reactive Protein for primary risk
assessment. In: Wu AHB (Ed.): Cardiac Markers. Humana Press:
2nd ed. New J ersey, 2003, P. 279-318.
4. Davidson MH. Surrogate Markers in Atherosclerosis. In: Feinstein
SB (Ed.): Non-Invasive Surrogate Markers of Atherosclerosis.
Informa: Chicago, 2008, P. 97-109.
5. Handojo I: Imunoasai Terapan pada Beberapa Penyakit Infeksi.
Airlangga University Press: Cetakan I. Surabaya, 2004, Hal. 272-
285.
6. Eckel RH. The Metabolic Syndrome. In: Fauci SA, Kasper DL,
Longo DL et all (Ed.): Harrisons Endocrinology. 2th Edition.
Medica: United State, 2010, P. 259-266.
7. Wild SH, Byrne CD. The Global Burden of the Metabolic Syndrome
and its Consequences for Diabetes and Cardiovascular Disease.
In: Byrne CD, Wild SH (Ed.): The Metabolic Syndrome. Wiley:
West Sussex, 2005, P. 1-32.
Universitas Sumatera Utara
8. Alberti KGM, Zimmet PZ. Metabolic Syndrome: Nomenclatur,
Definition, and Diagnosis. In: Krentz AJ and Wong ND (Ed.):
Metabolic Syndrome and Cardiovascular Disease. Informa
Healthcare USA: New York, 2007,p. 1-16.
9. Mittal S: The Metabolic Syndrome in Clinical Practice. Springer:
London, 2008, P.1-16; 36-56.
10. Forouchi NG. Ethnicity and The Metabolic Syndrome. In: Byrne
CD, Wild SH (Ed.): The Metabolic Syndrome. Wiley: West Sussex,
2005, P. 43-76.
11. Soegondo S: Obesitas pada Sindroma Metabolik : Penyebab atau
Akibat. Editor: Setiati S, Alwi I, Simadibrata M, Sari NK, Chen K.
Dalam : Naskah Lengkap Pertemuan Ilmiah Tahunan (PIT) Ilmu
Penyakit Dalam 2005. Departemen Penyakit Dalam UI: J akarta,
2005, p. 83-86
12. Pranoto A, Kholili U, Tjoktoprawiro A dkk: Metabolic Syndrome as
Observed in Surabaya.
13. Soewondo P, Purnamasari D, Oemardi M, Waspadji S, Soegondo
S: Prevalence of Metabolic Syndrome Using NCEP/ATP III Criteria
in Jakarta, Indonesia: The Jakarta Primary Non-communicable
Disease Risk Factors Surveillance 2006. Acta Med Indones-
Indones J Intern Med. : 2010, p. 199-203.
Universitas Sumatera Utara
14. Kamso S: Body Mass Index, Total Cholesterol, and Ratio Total to
HDL Cholesterol were Determinants af Metabolic Syndrome in the
Indonesian elderly. Med J Indones: 2007,p. 195-200.
15. Ridker PM, Buring J E, Cook NR, Rifai N: C-Reaktive Protein, the
Metabolic Syndrome, and Risk of Incident Cardiovascular Events.
Circulation: 2003,p. 391-397.
16. Ridker PM, Wilson PWF, Grundy SM: Should C-Reaktive Protein
be added to Metabolic Syndrome and to Assessment of Global
Cardiovascular Risk. Circulation: 2004,p. 2818-2825.
17. Oliveira AC, Oliveira AM, Adan LF et all: C-Reactive Protein and
Metabolic Syndrome in Youth: A Strong Relationship. Nature
Publishing Group: 2008, p. 1094-1098.
18. Huffman FG, Gomez GP, Zarini GG: Metabolic Syndrome and
High-Sensitivity C-Reactive Protein in Cubans. Spring Ethnicity and
Disease: Vol.19, 2009, p. 115-120.
19. El-shorbagy HH, Ghoname IA: High-sensitivity C-Reaktive Protein
as a marker of Cardivascular risk in obese children and
adolescents. Health: 2010,p. 1078-1084.
20. Mattsson N, Magnussen CG, Ronnemaa T et all: Metabolic
Syndrome and Carotid Intima-Media Thickness in Young
Adults:Roles of Apolipiprotein B, Apolipoprotein A1, C-Reaktive
Protein, and Secretory Phospholipase A2:the Cardiovascular Risk
Universitas Sumatera Utara
in Young Finns Study. http://atvb.ahajournals.org.: 2010,p. 1861-
1866.
21. Capuzzi DM, Freeman J S: C-Reactive Protein and Cardiovascular
Risk in the Metabolic Syndrome and Type 2 Diabetes. Clinical
Diabetes: Vol.25, 2007, p. 16-22.
22. Pepys MB, Hirschfield GM: C-Reactive Protein:a Critical Update.
The J ournal of Clinical Investigation: Vol.111, 2003,p. 1805-1811.
23. Kresno SB: Diagnosis dan Prosedur Laboratorium. Edisi 4. Balai
Penerbit FK-UI: J akarta, 2001, Hal. 60-63.
24. Ivan Roit: Protein-protein fase akut dalam Essential Imunologi.
Edisi 8. Penerbit Widya Medika: J akarta, 2003, Hal. 16-22.
25. Tietz: Clinical Chemistry and Molecular Diagnostics. 4th edition.
Saunders: Missouri, 2006, P. 543-546.
26. J .B.Henry. Clinical Diagnosis and Management by Laboratory
Methods. 20th Edition. Saunders, Philadelphia, 2001, P. 259-262.
27. Verma S, Szmitko PE, Yeh ET: C-Reactive Protein: Structure and
Function. Circulation: 2004, Vol.109,p. 1914-1917.
28. Roche Diagnostic GmbH.: CRPHS Roche diagnostics.
Indianapolis: 2011. P.1-4.
29. Opie LH: Metabolic Syndrome.Circulation: 2007,p. e32-e35
30. International Diabetes Federation. The IDF consensus worldwide
definition of the metabolic syndrome. Belgium.
Universitas Sumatera Utara
31. Coppack S, Ali VM, Karpe F. Metabolic Syndrome: Insulin
resistance, obesity, Diabetes Mellitus, Hypertension, Phisical
Activity and Genetic Factors. In: Stanner S (Ed.). Cardiovascular
Disease. Blackwell Publishin:, Australia, 2005, P. 22-49
32. J idi C, Cockram C, Gin HK et all: The Asia-Pasific Perspective:
Redefining Obesity and its treatment. Health Communications
Australia: Australia, 2000, P. 9-20.
33. Cinti Saverio. The Adipose Organ. In: Fantuzzi G, Mazzone T
(Ed.). Nutrition and Health: Adipose tissue and adipokines in
Health and disease. Humana Pres: New J erssey, 2005, P.3-17
34. Diewald L, Dolan MS, Faith MS. Environmental Aspects of Obesity.
In: Fantuzzi G, Mazzone T (Ed.). Nutrition and Health: Adipose
tissue and Adipokines in Health and Disease. Humana Press: New
J erssey, 2005, P. 197-204
35. Matsuzawa Y. Adiponectin and inflammation.In: Fantuzzi G,
Mazzone T (Ed.). Nutrition and Health: Adipose tissue and
Adipokines in Health and Disease. Humana Press: New J erssey,
2005,P. 111-116
36. J awa A and Fonseca V. Metabolic Syndrome and Type 2 Diabetes
Mellitus. In: Krentz AJ and Wong ND (Ed.): Metabolic Syndrome
and Cardiovascular Disease. Informa Healthcare: USA, New York,
2007, P. 41-78
Universitas Sumatera Utara
37. Hu G, Lakka TA, Lakka HM, Tuomilehto J . Obesity, Physical
Activity, and Nutrition in the Metabolic Syndrome. In: Krentz AJ and
Wong ND (Ed.): Metabolic Syndrome and Cardiovascular Disease.
Informa Healthcare: USA, New York, 2007, P. 241-278
38. Gerich J E and Dodis R. Glycemic Control and the Metabolic
Syndrome. In: Krentz AJ and Wong ND (Ed.): Metabolic
Syndrome and Cardiovascular Disease. Informa Healthcare: USA,
New York, 2007, P. 145-190
39. Franklin SS. Hypertension in the Metabolic Syndrome. In: Krentz
AJ and Wong ND (Ed.): Metabolic Syndrome and Cardiovascular
Disease. Informa Healthcare: USA, New York, 2007,P. 219-240
40. Volkava NB and Deedwania. Dyslipidemia in the Metabolic
Syndrome. In: Krentz AJ and Wong ND (Ed.): Metabolic Syndrome
and Cardiovascular Disease. Informa Healthcare: USA, New York,
2007, P. 191-218
41. Reilly MP and Rader DJ : The Metabolic Syndrome: More Than the
Sum of Its Parts? Circulation: 2003, p.108: 1546-1551
42. Haffner SM: The Metabolic Syndrome: Inflammation, Diabetes
Mellitus, and Cardiovascular Disease. Saunders: 2006,p. 3A-11A
43. Rutter MK, Meigs J B, Sullivan LM, DAgostino RB and Wilson
PWF: C-Reactive Protein, the Metabolic Syndrome, and Prediction
of Cardiovascular Events in the Framingham Offspring Study.
Circulation: 2004,p.110: 380-385.
Universitas Sumatera Utara
44. Wahyuni AS: Statistika Kedokteran. Bamboedoea Communication:
J akarta Timur, 2010, Hal.120-121; 137-144.
45. Abbas AK,Lichtman AH,Pillai S: Cellular and Molecular
Immunology. 7th Ed. Saunders: Philadelphia,2009;p: 55-88.
46. Verma Subodh, Szmitko PE and Yeh E.T: C-Reactive Protein :
Structure affect Function. Circulation: 2004, p.109 :1914-1917
47. Vinayak Hegde and Ishmael Ching (2012). Vascular Inflammation:
A New Horizon in Cardiovascular Risk Assessment. In: Gasparyan
A (Ed.). Cardiovascular Risk Factors. In Tech: Ohio,2012, P. 103-
140.
48. Filep J G: Platelets Affect the Structure and Function of C-Reactive
Protein. American Heart Association: Dallas,2009, p. 105:109-111.
49. Osterud B, Bjorklid E: Role of Monocytes in Atherogenesis.
American Physiological Society: 2003, p. 83:1069-1112.
50. Hage FG, Szalai AJ : C-Reactive Protein Gene Polymorphisms, C-
Reactive Protein Blood Levels, and Cardiovascular Disease Risk.
American College of Cardiology Foundation: Saunders, 2007, p.
1115-1122.


Universitas Sumatera Utara